期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Therapeutic Advances in Neurological Disorders LetPub Score 7.3
50 ratings
Rate
Reputation 8.3 Influence 6.2 Speed 8.8 | ||||||||||||||||||||||||
期刊簡稱 | THER ADV NEUROL DISO | ||||||||||||||||||||||||
ISSN | 1756-2856 | ||||||||||||||||||||||||
E-ISSN | 1756-2864 | ||||||||||||||||||||||||
h-index | 40 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.10%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://journals.sagepub.com/home/tan | ||||||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/tand | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | SAGE Publications Inc. | ||||||||||||||||||||||||
主題領域 | CLINICAL NEUROLOGY | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 継続刊行 | ||||||||||||||||||||||||
創刊年 | 2008 | ||||||||||||||||||||||||
每年文章數 | 88每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 94.19% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( USD2650; ) APC waiver:Check Notes Other charges: No Keywords: neurological disorders、neurology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-2856%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 15 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Therapeutic Advances in Neurological Disorders] 的評論 | 撰寫評論 |
作者: 犬走今雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 20:54:42 評論於 How much is the fee?(0) 讚! | 犬走今雨 |
作者: 筑阳绮艳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-03 17:21:31 評論於 Review speed: 2.0 | Submission acceptance rate: 95.0 Experience sharing: I submitted an article, and the first review took about a month, which provided some feedback and suggestions. The second review also took around a month, but overall it went quite smoothly(0) 讚! | 筑阳绮艳 |
作者: Michelle Doris 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-02 22:56:55 評論於 Review Speed: 3.0 | Acceptance Rate: 75.0 Experience Sharing: I heard from my senior sister that this journal is quite recognized by peers. I checked the high-quality medical journals in the 2nd area of the Chinese Academy of Sciences, and the self-citation rate has always been very low at 3.7%. I will pay special attention to it(0) 讚! | Michelle Doris |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-28 19:48:46 評論於 This journal has a high impact in the field of neuroscience, and I think it is well-deserved to be included in the JCR Q1 journal list(0) 讚! | 上清雨真 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-28 09:17:47 評論於 Submission publication time: Generally, one month for the first review, one month for the second review, with a total duration of 2-3 months for acceptance(0) 讚! | Darlene Pepys |
作者: 风陵松月 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-05 20:23:48 評論於 Review speed: 2.0 | Submission success rate: 50.0 Emphasized research direction: neurology Experience sharing: relatively friendly to Chinese researchers. The professionalism of the journal editors is quite high. Four reviewers provided 2 rounds of reviews consecutively, and their comments were quite professional. The journal's processing speed is average, taking nearly half a year from submission to acceptance(0) 讚! | 风陵松月 |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-25 13:23:51 評論於 Hasn't it been sent for external review for so long?(0) 讚! | 韦陀丽萍 |
作者: 龙鳞代梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-23 15:08:20 評論於 It's been almost 2 months since my article was submitted. I'm starting to wonder if I should withdraw it(0) 讚! | 龙鳞代梅 |
作者: 宗室哲圣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-05 14:52:16 評論於 Oh my goodness, it's been over a month and still no progress on sending it out for review. No response even after reminders(0) 讚! | 宗室哲圣 |
作者: 东风昆纶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-27 20:38:57 評論於 I F expected 6(0) 讚! | 东风昆纶 |
作者: 东风昆纶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-15 11:13:53 評論於 Review speed: 3.0 | Submission hit rate: 75.0 Experience sharing: What is the forecast for 2022?(0) 讚! | 东风昆纶 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:36:25 評論於 Revised, that is, modified reply. In the submission and publication of papers in SCI journals, it is a step to make appropriate modifications in response to editor's letter and to explain the modified content in detail in the reply letter to the editor, requesting a re-review of the manuscript(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:29:57 評論於 Revised, i.e. the modified reply. We need to provide detailed responses to the modifications suggested by the reviewer(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 14:56:52 評論於 What does recuperation involve?(0) 讚! | Darlene Pepys |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 16:09:42 評論於 What is meant by recycling?(0) 讚! | 北国博达 |
作者: 珉林高峰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-13 11:54:38 評論於 This weight loss program involves a combination of healthy eating and regular exercise(0) 讚! | 珉林高峰 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-19 13:40:42 評論於 Experience Sharing: The reason why this journal is good is that it has a dedicated executive editor who can make many decisions and speed up the review process. Many journals require the opinions of 2-3 reviewers to be unified, so the editor can quickly come to a conclusion. However, if the opinions are not unified and the editor cannot make a decision, it may be necessary to find another reviewer for arbitration, which will prolong the review process. This is one of the reasons why many people have excessively long review times(0) 讚! | 龙鳞孝礼 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-18 16:10:47 評論於 The strength of high-quality journals lies in their professional and efficient peer review process! During the submission period, I communicated multiple times with the editorial board members, and I feel that the editorial board of this journal is very high in level and efficiency. I truly commend them!(0) 讚! | 龙鳞孝礼 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-13 15:46:38 評論於 I saw that some experts who have submitted manuscripts said that this journal has an exclusive handling editor. Does it mean the review process will be much faster than other journals?(0) 讚! | 修然小公主 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-05 19:17:32 評論於 Although the number of articles published in this journal is not large, the quality of the articles is quite high. It's a good journal, recommended!(0) 讚! | 修然小公主 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-04 15:50:36 評論於 I heard that this journal has a small number of publications. I was a little nervous when submitting the manuscript for the first time in May, and I just received an email with the proof and payment request. It seems like I need to have a little more confidence in myself!(0) 讚! | 修然小公主 |
作者: lorp 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-08-31 14:46:28 評論於 The annual number of published papers is small, but the quality of each article is very high. The editors must have been very careful in choosing the manuscripts. (0) 讚! | lorp |
作者: 岭南子贺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-31 09:46:57 評論於 This journal excellently embodies the principle of valuing quality over quantity in military affairs. Although the annual number of publications is low, the quality of each article is very high, indicating that the editors carefully select the submissions(0) 讚! | 岭南子贺 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us